Order Article Reprints

Shiuan E, Reddy A, Dudzinski SO, Lim AR, Sugiura A, Hongo R, Young K, Liu X-D, Smith CC, O’Neal J, et al. Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma. Cancers. 2021; 13(6):1475. https://doi.org/10.3390/cancers13061475

Shiuan, Eileen, Anupama Reddy, Stephanie O. Dudzinski, Aaron R. Lim, Ayaka Sugiura, Rachel Hongo, Kirsten Young, Xian-De Liu, Christof C. Smith, Jamye O’Neal, and et al. 2021. "Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma" Cancers 13, no. 6: 1475. https://doi.org/10.3390/cancers13061475

Shiuan, E., Reddy, A., Dudzinski, S. O., Lim, A. R., Sugiura, A., Hongo, R., Young, K., Liu, X.-D., Smith, C. C., O’Neal, J., Dahlman, K. B., McAlister, R., Chen, B., Ruma, K., Roscoe, N., Bender, J., Ward, J., Kim, J. Y., Vaupel, C., ... Beckermann, K. E. (2021). Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma. Cancers, 13(6), 1475. https://doi.org/10.3390/cancers13061475